The Pathophysiology and Management of Acute Traumatic Coagulopathy

被引:13
作者
Duan, Kaipeng [1 ]
Yu, Wenkui [1 ]
Li, Ning [1 ]
机构
[1] Nanjing Univ, Sch Med, Jinling Hosp, Dept Gen Surg, Nanjing 210002, Jiangsu, Peoples R China
关键词
trauma; coagulopathy; mechanism; treatment; DISSEMINATED INTRAVASCULAR COAGULATION; ACTIVATED FACTOR-VII; ENDOTHELIAL GLYCOCALYX DEGRADATION; PROTEIN-C; FIBRINOGEN METABOLISM; TRANEXAMIC ACID; INFLAMMATION; RESUSCITATION; HEMORRHAGE; DAMAGE;
D O I
10.1177/1076029613516190
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Acute traumatic coagulopathy (ATC) is commonly seen among patients with severe injury and will lead to uncontrolled bleeding diathesis, which is an important contributor to trauma death. During the past 10 years, the understanding of the mechanism causing ATC has changed rapidly. The mechanisms for ATC are complicated. To date, the possible mechanisms include activation of protein C, shedding of endothelial glycocalyx, catecholamine release, platelet dysfunction, primary, and secondary fibrinolysis, with tissue injury and hypoperfusion as the triggers. Classic factors such as dilution, acidosis, and hypothermia can further aggravate the coagulopathy. Inflammation may have a potential effect on the onset and prognosis of ATC. With the aid of diagnostic device, the outcome can be improved through early and customized treatment. Antifibrinolytics such as tranexamic acid has some benefits in patients with bleeding trauma, especially in the early time. This review presents the current understanding of ATC mechanisms and management.
引用
收藏
页码:645 / 652
页数:8
相关论文
共 84 条
  • [1] Thrombin-induced platelet PAR4 activation:: role of glycoprotein Ib and ADP
    Adam, F
    Verbeuren, TJ
    Fauchère, JL
    Guillin, MC
    Jandrot-Perrus, M
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (04) : 798 - 804
  • [2] The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome
    Aird, WC
    [J]. BLOOD, 2003, 101 (10) : 3765 - 3777
  • [3] Off-Label Use of Recombinant Activated Factor VII -- Safe or Not Safe?.
    Aledort, Louis M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (19) : 1853 - 1854
  • [4] [Anonymous], 2011, LANCET, DOI DOI 10.1016/S0140-6736(11)60278-X
  • [5] Thrombin activatable fibrinolysis inhibitor: Not just an inhibitor of fibrinolysis
    Bajzar, L
    Jain, N
    Wang, P
    Walker, JB
    [J]. CRITICAL CARE MEDICINE, 2004, 32 (05) : S320 - S324
  • [6] The profibrinolytic effect of activated protein C in clots formed from plasma is TAFI-dependent
    Bajzar, L
    Nesheim, ME
    Tracy, PB
    [J]. BLOOD, 1996, 88 (06) : 2093 - 2100
  • [7] Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: Two parallel randomized, placebo-controlled, double-blind clinical trials
    Boffard, KD
    Riou, B
    Warren, B
    Choong, PIT
    Rizoli, S
    Rossaint, R
    Axelsen, M
    Kluger, Y
    [J]. JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2005, 59 (01): : 8 - 16
  • [8] Acute traumatic coagulopathy
    Brohi, K
    Singh, J
    Heron, M
    Coats, T
    [J]. JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2003, 54 (06): : 1127 - 1130
  • [9] Acute coagulopathy of trauma: Hypoperfusion induces systemic anticoagulation and hyperfibrinolysis
    Brohi, Karim
    Cohen, Mitchell J.
    Ganter, Michael T.
    Schultz, Marcus J.
    Levi, Marcel
    Mackersie, Robert C.
    Pittet, Jean-Francois
    [J]. JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2008, 64 (05): : 1211 - 1217
  • [10] Acute coagulopathy of trauma: mechanism, identification and effect
    Brohi, Karim
    Cohen, Mitchell J.
    Davenport, Ross A.
    [J]. CURRENT OPINION IN CRITICAL CARE, 2007, 13 (06) : 680 - 685